An ongoing trial of Zepbound (tirzepatide) is testing effects on heart disease in people with obesity and diabetes. Credit: Shelby Knowles/Bloomberg via Getty As appetite for blockbuster weight-loss drugs grows worldwide, scientists are developing the next crop of medications that, they hope, will improve the performance of these drugs and offer benefits beyond weight loss.
